Pancreatic Cancer Research

ResearcherUppsala UniversityActive in the last 2 years

Christopher Månsson

Matched on OpenAlex author ID A5013770210. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 9

  1. R0 Resection improves survival after multivisceral resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2026.117352↗
  2. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  3. Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. Co-author DOI 10.1186/s12893-025-02983-w↗
  4. Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice. Co-author DOI 10.1080/00365521.2024.2378948↗
  5. Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection. Co-author DOI 10.21873/anticanres.14249↗
  6. Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13371↗
  7. The Value of CA19-9 After Irreversible Electroporation for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13827↗
  8. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. Co-author DOI 10.1016/j.ejso.2016.01.024↗
  9. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer. Co-author PMID 24403476↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Britt‐Marie Karlson · 5 shared papers, 2014–2020 · strength 0.54
  2. Anders Nilsson · 5 shared papers, 2014–2020 · strength 0.54
  3. Bergþór Björnsson · 2 shared papers, 2024–2025 · strength 0.36
  4. Asif Halimi · 2 shared papers, 2024–2025 · strength 0.36
  5. Ernesto Sparrelid · 2 shared papers, 2024–2025 · strength 0.36
  6. Nils O. Elander · 1 shared paper, 2025 · strength 0.20
  7. Kristina Hasselgren · 1 shared paper, 2025 · strength 0.20
  8. Heikki I. Huhta · 1 shared paper, 2025 · strength 0.20
  9. Poya Ghorbani · 1 shared paper, 2025 · strength 0.20
  10. Maria Gustafsson Liljefors · 1 shared paper, 2025 · strength 0.20
  11. Margareta Heby · 1 shared paper, 2025 · strength 0.20
  12. Daniel Öhlund · 1 shared paper, 2025 · strength 0.20
  13. Bodil Andersson · 1 shared paper, 2024 · strength 0.16
  14. Svein Olav Bratlie · 1 shared paper, 2024 · strength 0.16
  15. Hanna E. Seppänen · 1 shared paper, 2024 · strength 0.16
  16. Bobby Tingstedt · 1 shared paper, 2024 · strength 0.16
  17. Johanna Laukkarinen · 1 shared paper, 2024 · strength 0.16
  18. Linn Såve Nymo · 1 shared paper, 2024 · strength 0.16
  19. Jakob Kirkegård · 1 shared paper, 2024 · strength 0.16
  20. Roland E. Andersson · 1 shared paper, 2024 · strength 0.16
  21. Daniel Ansari · 1 shared paper, 2024 · strength 0.16
  22. Carsten Palnæs Hansen · 1 shared paper, 2024 · strength 0.16
  23. Knut Jørgen Labori · 1 shared paper, 2024 · strength 0.16
  24. Kjetil Søreide · 1 shared paper, 2024 · strength 0.16
  25. Saila P. Kauhanen · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.